Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States, Funding Opportunity Announcement (FOA) IP08-00101SUPP10, Initial Review

---
identifier: "/us/fr/E9-22154"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States, Funding Opportunity Announcement (FOA) IP08-00101SUPP10, Initial Review"
title_number: 0
title_name: "Federal Register"
section_number: "E9-22154"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States, Funding Opportunity Announcement (FOA) IP08-00101SUPP10, Initial Review"
positive_law: false
currency: "2009-09-15"
last_updated: "2009-09-15"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-22154"
document_type: "notice"
publication_date: "2009-09-15"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "74 FR 47262"
fr_volume: 74
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States, Funding Opportunity Announcement (FOA) IP08-00101SUPP10, Initial Review

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Date:* 10 a.m.-11 a.m., September 25, 2009 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the initial review, discussion, and evaluation of “Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States, FOA IP08-00101SUPP10.”

*Contact Person for More Information:* Gregory Anderson, M.P.H., M.S., CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, GA 30333, *Telephone:* (404) 498-2275.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: September 4, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.